FundedIQ
Biotechnology

Soley Therapeutics: Funding, Investors & Team (Oct 2026)

Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs, using image acquisition-based approaches. Soley Therapeutics has taken an orthogonal approach to discover new drugs by developing a technology platform to measure how cells respond multi-dimensionally in response to drugs. We have developed a novel platform for high-content phenotypic drug screening, where the drug effect on a cell can be visualized via molecular-microscopic images and analyzed by using sophisticated AI tools.

soleytherapeutics.com LinkedIn San Francisco, United States 11-50 employees
Total raised
$200M
Rounds
1
Latest
Series C
Jan 2026

Soley Therapeutics has raised $200M across 1 funding round on record, the most recent a Series C of $200M announced in Jan 2026.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Soley Therapeutics Company Profile and Key Stats

Total funding raised
$200M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series C
$200M in Jan 2026
Employees
11-50
reported band
Headquarters
San Francisco, United States

Latest funding round on record: Jan 2026.

Soley Therapeutics Funding Rounds

Date
Round
Amount
Series C
$200M

Soley Therapeutics Founders and Leadership Team

Name
Role
Contact
Yerem Yeghiazarians
Founder
Locked

Contact details for the Soley Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Soley Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
1,877
$60M

Soley Therapeutics' latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Soley Therapeutics in Biotechnology and San Francisco

Companies Similar to Soley Therapeutics

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Soley Therapeutics Funding FAQs

What does Soley Therapeutics do?

Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs, using image acquisition-based approaches. Soley Therapeutics has taken an orthogonal approach to discover new drugs by developing a technology platform to measure how cells respond multi-dimensionally in response to drugs. We have developed a novel platform for high-content phenotypic drug screening, where the drug effect on a cell can be visualized via molecular-microscopic images and analyzed by using sophisticated AI tools.

How much funding has Soley Therapeutics raised?

Soley Therapeutics has raised $200M across 1 round on record. The most recent is a Series C of $200M announced in Jan 2026.

When did Soley Therapeutics last raise funding?

Soley Therapeutics' most recent funding round on record is a Series C of $200M, announced in Jan 2026.

Who founded Soley Therapeutics?

FundedIQ lists Yerem Yeghiazarians (Founder) at Soley Therapeutics.

Where is Soley Therapeutics headquartered?

Soley Therapeutics is based in San Francisco, California, United States.

How many employees does Soley Therapeutics have?

Soley Therapeutics is in the 11-50 employee band.

How does Soley Therapeutics' funding compare to other Biotechnology startups?

Soley Therapeutics' latest round of $200M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Soley Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Soley Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.